{"entity":{"id":"nct01377220","kind":"trial","name":"Evaluation of 11 C-Choline PET-CT for Detection of Hepatocellular Carcinoma","aka":[],"tldr":"A phase 2 trial of Choline C-11 in Hepatocellular carcinoma, run by Commissariat A L'energie Atomique, with a status the registry has not verified recently.","summary":"Evaluation of 11 C-Choline PET-CT for Detection of Hepatocellular Carcinoma is a phase 2 interventional study registered as NCT01377220 by Commissariat A L'energie Atomique, with 30 participants planned, started 2011-06 and due to reach its primary completion in 2013-06. Interventions recorded: 11C-Choline. Conditions recorded: Hepatocellular Carcinoma.\n\nLinked to the drug Choline C-11 because the registry names it among its interventions and Hepatocellular carcinoma among its conditions. Registry record only: no result has been read by an editor.","asOf":"2026-09-22","links":[{"label":"ClinicalTrials.gov NCT01377220","url":"https://clinicaltrials.gov/study/NCT01377220"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["hcc"],"sections":[],"technologies":[],"targets":[],"drugs":["choline-c11"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT01377220","phase":"2","setting":"Evaluation of 11 C-Choline PET-CT for Detection of Hepatocellular Carcinoma","sponsor":"Commissariat A L'energie Atomique","enrolled":30,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct01377220/","neighbours":{"cancer":[{"id":"hcc","kind":"cancer","name":"Hepatocellular carcinoma","route":"/cancers/hcc/"}],"drug":[{"id":"choline-c11","kind":"drug","name":"Choline C-11","route":"/drugs/choline-c11/"}]}}